Sublingual immunotherapy safe, effective for treating toddlers’ peanut allergy
Outcomes were better in children who were younger at initiation, the authors write.
Peanut sublingual immunotherapy is safe and effective at inducing desensitisation and remission in preschoolers, a US study shows.
Researchers from the University of North Carolina at Chapel Hill looked at peanut sublingual immunotherapy (SLIT) for peanut allergy in 50 children, aged one to four years old,
